These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35740569)

  • 1. MALAT1 as a Regulator of the Androgen-Dependent Choline Kinase A Gene in the Metabolic Rewiring of Prostate Cancer.
    De Martino S; Iorio E; Cencioni C; Aiello A; Spallotta F; Chirico M; Pisanu ME; Grassi C; Pontecorvi A; Gaetano C; Nanni S; Farsetti A
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9
    Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C
    Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.
    Audet-Walsh É; Dufour CR; Yee T; Zouanat FZ; Yan M; Kalloghlian G; Vernier M; Caron M; Bourque G; Scarlata E; Hamel L; Brimo F; Aprikian AG; Lapointe J; Chevalier S; Giguère V
    Genes Dev; 2017 Jun; 31(12):1228-1242. PubMed ID: 28724614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
    Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
    PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells.
    Dai X; Liu L; Liang Z; Guo K; Xu S; Wang H
    Pathol Res Pract; 2019 Apr; 215(4):712-721. PubMed ID: 30642743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Reprogramming by Malat1 Depletion in Prostate Cancer.
    Nanni S; Aiello A; Salis C; Re A; Cencioni C; Bacci L; Pierconti F; Pinto F; Ripoli C; Ostano P; Baroni S; Lazzarino G; Tavazzi B; Pugliese D; Bassi P; Grassi C; Panunzi S; Chiorino G; Pontecorvi A; Gaetano C; Farsetti A
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
    Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
    Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer.
    Challapalli A; Trousil S; Hazell S; Kozlowski K; Gudi M; Aboagye EO; Mangar S
    J Clin Pathol; 2015 Sep; 68(9):703-9. PubMed ID: 26041862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
    Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D
    Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of androgen receptor binding sites in prostate cancer cells.
    Cheng Y; Yu P; Duan X; Liu C; Xu S; Chen Y; Tan Y; Qiang Y; Shen J; Tao Z
    Exp Ther Med; 2015 Jun; 9(6):2319-2324. PubMed ID: 26136980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells.
    Fan Z; Ma J; Pan X; Zhao L; Wu Y; Lin H; Zhao Y; Jiang H; Pan T; Li X; Wang F; Wang C
    Int J Cancer; 2022 May; 150(9):1525-1536. PubMed ID: 34985768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.
    He HJ; Gu XF; Xu WH; Yang DJ; Wang XM; Su Y
    Acta Pharmacol Sin; 2013 Feb; 34(2):282-8. PubMed ID: 23023312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells.
    Patel D; Chinaranagari S; Chaudhary J
    Am J Cancer Res; 2015; 5(11):3407-21. PubMed ID: 26807321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells.
    Karacosta LG; Kuroski LA; Hofmann WA; Azabdaftari G; Mastri M; Gocher AM; Dai S; Hoste AJ; Edelman AM
    Prostate; 2016 Feb; 76(3):294-306. PubMed ID: 26552607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
    Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
    NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis.
    Wu G; Aoyama C; Young SG; Vance DE
    J Biol Chem; 2008 Jan; 283(3):1456-1462. PubMed ID: 18029352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
    Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.